rigel pharmaceuticals stock

Rigel Pharmaceuticals Stock Performance RIGL stock opened at 074 on Friday. Common Stock RIGL Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets.

Rigel Pharmaceuticals Rigl 52 Week High At 3 57 Low At 0 67

Company Financials 7 Analysts RIGL Stock Overview Rigel Pharmaceuticals Inc a biotechnology company discovers and develops small molecule drugs to treat hematologic.

. The Company is engaged in discovering developing and providing small molecule drugs that improve the lives. Get Rigel Pharmaceuticals Inc RIGLNASDAQ real-time stock quotes news price and financial information from CNBC. Real time Rigel Pharmaceuticals RIGL stock price quote stock graph news analysis. Find the latest Rigel Pharmaceuticals Inc.

Conclusions and financial information. The company has a quick ratio of 208 a current ratio of 219 and a debt-to-equity ratio of 439. Is a biotechnology company. Stocks options futures ETFs and REITs.

According to the current price Rigel Pharmaceuticals is 2092 away from the 52-week high. Trade multiple securities at your fingertips. Rigel Pharmaceuticals Inc a biotechnology company discovers and develops small molecule drugs to treat hematologic disorders cancer and rare immune diseases. What are analysts forecasts for Rigel Pharmaceuticals stock.

Operates as a clinical stage biotechnology. Discover historical prices for RIGL stock on Yahoo Finance. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Real-time trade and investing ideas on Rigel Pharmaceuticals RIGL from the largest community of traders and investors.

Share your opinion and gain insight from other stock traders and investors. Welcome to Rigel Rigel Pharmaceuticals is a biotechnology company dedicated to discovering developing and providing novel small molecule drugs that significantly improve the lives of. Get the latest Rigel Pharmaceuticals Inc. View daily weekly or monthly format back to when Rigel Pharmaceuticals Inc.

A high-level overview of Rigel Pharmaceuticals Inc. HC Wainwright lifted their target price on Rigel Pharmaceuticals from 700 to 1500 and gave the stock a buy rating in a research report on Thursday August 18th. Find real-time RIGL - Rigel Pharmaceuticals Inc stock quotes company profile news and forecasts from CNN Business. RIGL had cash cash equivalents and short-term investments of 125M per share as of year-end 2021 and notes that it took on an additional 10M from its credit facility in.

RIGL real-time quote historical performance charts and other financial information to help you make more informed trading and investment. RIGL stock discussion in Yahoo Finances forum. Ad 0 Account Maintenance Fees and No Minimum Deposit Requirement. The stock currently trades just under two bucks a share and sports an approximate market capitalization of 310 million.

November 3 2022 305 PM 3 min read Rigel Pharmaceuticals RIGL came out with a quarterly loss of 011 per share versus the Zacks Consensus Estimate of a loss of 013. As of July 29 2022 there were 172836336 shares of RIGLs stock outstanding corresponding to a market cap of 1227M at 071 per. The company has one approved product called Tavalisse. Shares Sold Short 717 M Change from Last -596 Percent of Float 420 Stock Money Flow NA PROFILE RIGL Rigel Pharmaceuticals Inc.